UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041035
Receipt number R000046861
Scientific Title A prospective study to examine the usefulness and safety of 6mm diameter covered metallic stent insertion for biliary drainage in patients with pancreatic cancer undergoing preoperative chemotherapy
Date of disclosure of the study information 2020/07/08
Last modified on 2022/07/20 15:59:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective study to examine the usefulness and safety of 6mm diameter covered metallic stent insertion for biliary drainage in patients with pancreatic cancer undergoing preoperative chemotherapy

Acronym

A prospective study to examine the usefulness and safety of 6mm diameter covered metallic stent insertion for biliary drainage in patients with pancreatic cancer undergoing preoperative chemotherapy

Scientific Title

A prospective study to examine the usefulness and safety of 6mm diameter covered metallic stent insertion for biliary drainage in patients with pancreatic cancer undergoing preoperative chemotherapy

Scientific Title:Acronym

A prospective study to examine the usefulness and safety of 6mm diameter covered metallic stent insertion for biliary drainage in patients with pancreatic cancer undergoing preoperative chemotherapy

Region

Japan


Condition

Condition

pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To prospectively examine the usefulness and safety of the covered metallic stent in patients with a 6 mm diameter covered metallic stent for biliary drainage in patients with pancreatic cancer undergoing preoperative chemotherapy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of recurrent biliary obstruction (RBO) that develops before surgery

Key secondary outcomes

(1)Time to recurrent biliary obstruction (TRBO)
(2) Incidence of cholecystitis
(3) Adverse events other than RBO
(4) Impact on surgery


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients aged 20 years or older at the time of obtaining consent
2)Patients diagnosed with pancreatic cancer by histological diagnosis or imaging tests (CT or MRI)
3) Patients with middle and lower bile duct stenosis
4) Patients who have been judged by a doctor to be able to place a self-expanding metal stent (SEMS)
5) Patients scheduled to undergo preoperative chemotherapy (NAC)
6) Patients scheduled for surgery
7) Patients who can obtain their consent for participation in this study

Key exclusion criteria

1) Patients with Performance status 3 or 4
2) Women who are pregnant or may be pregnant
3) Patients with severe complications that affect resection or chemotherapy such as heart disease, liver disease, renal disorder
4) Patients with a distance from the hilum of the stenosis to the upper end of the stenosis of 2 cm
5) Patients with Gastic outlet obstruction due to anal stenosis
6) Cases where endoscopic approach is difficult
7) Reconstruction other than Billroth 1 method after gastrectomy
8) Cases with distant metastasis
9) Patients who are judged to be inappropriate as a subject by the doctor's judgment

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Yasumi
Middle name
Last name Katayama

Organization

Dokkyo Medical University Saitama Medical Center

Division name

Gastroenterology

Zip code

343-8555

Address

2-1-50,Minami Koshigaya,Koshigaya-shi,Saitama

TEL

048-965-1111

Email

yasumi@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Ikuhiro
Middle name
Last name Kobori

Organization

Dokkyo Medical University Saitama Medical Center

Division name

Gastroenterology

Zip code

343-8555

Address

2-1-50,Minami Koshigaya,Koshigaya-shi,Saitama

TEL

048-965-1111

Homepage URL


Email

viva.s.a.410@gmail.com


Sponsor or person

Institute

Dokkyo Medical University Saitama Medical Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Dokkyo Medical University Saitama Medical Center

Address

2-1-50,Minami Koshigaya,Koshigaya-shi,Saitama

Tel

048-965-1111

Email

m-iyama@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2020 Year 05 Month 18 Day

Date of IRB

2020 Year 06 Month 15 Day

Anticipated trial start date

2020 Year 07 Month 09 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study


Management information

Registered date

2020 Year 07 Month 08 Day

Last modified on

2022 Year 07 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046861


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name